Welcome!
UOB Kay Hian (UOBKH)
Broker's Calls
Analysts keep ‘buy’ on Frencken, optimistic on better 2HFY2024
Frencken's 1HFY2024 earnings of $18 million were in-line with UOB's and Maybank's expectations, but slightly below DBS's.
August 19, 2024
Broker's Calls
Analysts see strength in Centurion Corp, keep ‘add’ or ‘buy’ at raised TPs
Analysts at CGSI, RHB and UOBKH have all raised their respective target prices of 78 cents, 76 cents and 85 cents.
August 16, 2024
Results
UOB Kay Hian reports earnings of $113.9 mil for 1HFY2024, 64.3% higher y-o-y
Revenue was up by 10.2% y-o-y to $317.1 million as all income – except interest income – rose on a y-o-y basis.
August 15, 2024
Broker's Calls
Analysts optimistic on CSE Global, all keep ‘add’ or ‘buy’ at raised or unchanged prices
Analysts at CGSI, UOBKH and Maybank have all been pleased with CSE Global's 1HFY2024 results, and are upbeat on further earnings.
August 09, 2024
Broker's Calls
UOBKH downgrades MLT to ‘hold’ after growth deceleration in 1QFY2025 and persistent weak outlook for China
The REIT’s reported DPU for the quarter came in below expectations at 2.068 cents, down 8.9% y-o-y.
July 30, 2024
Broker's Calls
Brokers' Digest: Prime US REIT, Hongkong Land, Yangzijiang Shipbuilding, SIA, CICT, ST Engineering, OUE REIT, Wilmar
See what the analysts say this week.
July 18, 2024
Broker's Calls
UOB Kay Hian raises CICT’s TP to $2.29 following continued enhancement of retail malls
Most notably, CICT’s has commenced its asset enhancement initiatives (AEI) at Level 1 of IMM Building, set for completion in 2025.
July 16, 2024
Broker's Calls
Analysts mixed on Keppel DC REIT after Japan data centre acquisition
UOB Kay Hian is keeping its “hold call” while Citi keeps its “buy” call.
July 12, 2024
Broker's Calls
UOBKH names Singtel as top pick in telco sector, CGSI raises TP to $3.30
Singtel’s share price has increased by 13% m-o-m, alongside other positive developments.
July 10, 2024
Broker's Calls
Brokers’ Digest: Mermaid Maritime, YZJ, MLT, Seatrium, Valuetronics, Singtel, Yoma Strategic, Raffles Medical, MPACT
See what the analysts have to say this week.
July 04, 2024